291 related articles for article (PubMed ID: 32460431)
1. Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma.
Hall Z; Chiarugi D; Charidemou E; Leslie J; Scott E; Pellegrinet L; Allison M; Mocciaro G; Anstee QM; Evan GI; Hoare M; Vidal-Puig A; Oakley F; Vacca M; Griffin JL
Hepatology; 2021 Mar; 73(3):1028-1044. PubMed ID: 32460431
[TBL] [Abstract][Full Text] [Related]
2. Deranged hepatocyte intracellular Ca
Ali ES; Rychkov GY; Barritt GJ
Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
[TBL] [Abstract][Full Text] [Related]
4. RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state.
Belenguer G; Mastrogiovanni G; Pacini C; Hall Z; Dowbaj AM; Arnes-Benito R; Sljukic A; Prior N; Kakava S; Bradshaw CR; Davies S; Vacca M; Saeb-Parsy K; Koo BK; Huch M
Nat Commun; 2022 Jan; 13(1):334. PubMed ID: 35039505
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via
Chen Y; Chen Z; Feng JH; Chen YB; Liao NS; Su Y; Zou CY
Cell Biol Int; 2018 Apr; 42(4):425-434. PubMed ID: 29144590
[TBL] [Abstract][Full Text] [Related]
6. Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease.
Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
Lipids Health Dis; 2020 Dec; 19(1):250. PubMed ID: 33298075
[TBL] [Abstract][Full Text] [Related]
7. Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma.
Matsumoto T; Takai A; Eso Y; Kinoshita K; Manabe T; Seno H; Chiba T; Marusawa H
Cancer Res; 2017 Nov; 77(22):6131-6143. PubMed ID: 28951464
[TBL] [Abstract][Full Text] [Related]
8. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte-specific protein 1: a novel regulator of hepatocellular proliferation and migration deleted in human hepatocellular carcinoma.
Koral K; Paranjpe S; Bowen WC; Mars W; Luo J; Michalopoulos GK
Hepatology; 2015 Feb; 61(2):537-47. PubMed ID: 25234543
[TBL] [Abstract][Full Text] [Related]
10. Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes.
Vacca M; Murzilli S; Salvatore L; Di Tullio G; D'Orazio A; Lo Sasso G; Graziano G; Pinzani M; Chieppa M; Mariani-Costantini R; Palasciano G; Moschetta A
Gastroenterology; 2013 Jun; 144(7):1518-1529.e3. PubMed ID: 23462179
[TBL] [Abstract][Full Text] [Related]
11. Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications.
Behnke MK; Reimers M; Fisher RA
Ann Hepatol; 2013 Jan-2014 Feb; 13(1):45-53. PubMed ID: 24378265
[TBL] [Abstract][Full Text] [Related]
12. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
[TBL] [Abstract][Full Text] [Related]
13. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
14. Type I Interferon Signaling Accelerates Liver Regeneration by Metabolic Modulation in Noninfectious Conditions.
Wu MS; Kuo YP; Lo YC; Tsai DJ; Lai CY; Chuang TH; Lin SY; Tsai WT; Chung PJ; Yu GY
Am J Pathol; 2021 Jun; 191(6):1036-1048. PubMed ID: 33753025
[TBL] [Abstract][Full Text] [Related]
15. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
Bai PS; Xia N; Sun H; Kong Y
J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
[TBL] [Abstract][Full Text] [Related]
16. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
17. Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma.
Vacca M; D'Amore S; Graziano G; D'Orazio A; Cariello M; Massafra V; Salvatore L; Martelli N; Murzilli S; Lo Sasso G; Mariani-Costantini R; Moschetta A
PLoS One; 2014; 9(8):e104449. PubMed ID: 25116592
[TBL] [Abstract][Full Text] [Related]
18. A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.
Schröder PC; Segura V; Riezu JI; Sangro B; Mato JM; Prieto J; Santamaría E; Corrales FJ
Funct Integr Genomics; 2011 Sep; 11(3):419-29. PubMed ID: 21562899
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma.
Wang Q; Tan Y; Jiang T; Wang X; Li Q; Li Y; Dong L; Liu X; Xu G
Cells; 2022 Mar; 11(7):. PubMed ID: 35406630
[TBL] [Abstract][Full Text] [Related]
20. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
